Free Trial

Predictive Oncology (POAI) Earnings Date, Estimates & Call Transcripts

Predictive Oncology logo
$0.96 -0.04 (-3.99%)
As of 04/14/2025 04:00 PM Eastern

Predictive Oncology Earnings Summary

Upcoming Q3
Earnings Date
May. 13Before Market OpensEstimated
Actual EPS
(Aug. 13)
-$0.68 Missed By -$0.68
Actual Revenue
(Aug. 13)
$0.28M

Predictive Oncology announced Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.68. Quarterly revenue was reported to be $0.28 million. With a trailing EPS of -$3.05, Predictive Oncology's earnings are expected to grow next year, from ($2.08) to ($0.13) per share.

Q2 2024 Earnings Resources

POAI Upcoming Earnings

Predictive Oncology's Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled on Wednesday, May 14, 2025 at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Predictive Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Predictive Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

POAI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

POAI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Predictive Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.10-$0.10-$0.10
Q2 20251-$0.09-$0.09-$0.09
Q3 20251-$0.10-$0.10-$0.10
Q4 20251$0.06$0.06$0.06
FY 20254($0.23)($0.23)($0.23)
Remove Ads

Predictive Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2025
(Estimated)
--------
8/13/2024Q2 2024--$0.68 -$0.68-$0.68-$0.28M
5/14/2024Q1 2024--$1.04 -$1.04-$1.04-$0.42M
3/28/2024Q4 2023--$0.85 -$0.85-$0.85-$0.34M
11/13/2023Q3 2023--$0.78 -$0.78-$0.78-$0.72M
8/10/2023Q2 2023--$0.95 -$0.95-$0.92-$0.49M
5/15/2023Q1 2023--$0.86 -$0.86-$0.86-$0.24M

Predictive Oncology Earnings - Frequently Asked Questions

Predictive Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on POAI's earnings history.

The conference call for Predictive Oncology's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Predictive Oncology's latest earnings report can be read online.
Read Transcript

Predictive Oncology (NASDAQ:POAI) has a recorded annual revenue of $1.62 million.

Predictive Oncology (NASDAQ:POAI) has a recorded net income of -$13.98 million. POAI has generated -$3.05 earnings per share over the last four quarters.

Predictive Oncology's earnings are expected to grow from ($2.08) per share to ($0.13) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:POAI) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners